Certolizumab Pegol ELISA (mAb-based)
Enzyme immunoassay for the specific and quantitative determination of free Certolizumab Pegol (Cimzia®) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Certolizumab Pegol. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Quality Control Certificates
Cimzia® is a trademark of UCB.
The Kit at a glance:
|Required Volume (µL)||10|
|Incubation Time (min)||160|
|Sample||Serum or Plasma|
|Package Size||96 Tests|
|Standard Range (µg/mL, 500x)||0-100|
|Detection Limit (ng/mL)||5|
|Spike Recovery (%)||>95|
|Shelf Life (years)||2|